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p300 Is Elevated in Systemic Sclerosis and Its
Expression Is Positively Regulated by TGF-b:
Epigenetic Feed-Forward Amplification of Fibrosis
Asish K. Ghosh1,5, Swati Bhattacharyya1, Robert Lafyatis2, Giuseppina Farina2, Jianxiu Yu3,
Bayar Thimmapaya4, Jun Wei1 and John Varga1
Fibrosis, the hallmark of systemic sclerosis (SSc), is characterized by persistent fibroblast activation triggered by
transforming growth factor-b (TGF-b). As the acetyltransferase p300 has a key role in fibrosis and its availability
governs the intensity of fibrotic responses, we investigated p300 expression in SSc and the molecular basis of its
regulation. We found that expression of p300 was markedly elevated in SSc skin biopsies and was induced by
TGF-b in explanted normal skin fibroblasts. Stimulation of p300 by TGF-b was independent of Smads and involved
the early-immediate transcription factor Egr-1 (early growth response 1), a key regulator of profibrotic TGF-b
signaling. Indeed, Egr-1 was both sufficient and necessary for p300 regulation in vitro and in vivo. Increased p300
accumulation in TGF-b-treated fibroblasts was associated with histone hyperacetylation, whereas p300 depletion,
or selective pharmacological blockade of its acetyltransferase activity, attenuated TGF-b-induced responses.
Moreover, TGF-b enhanced both p300 recruitment and in vivo histone H4 acetylation at the COL1A2 (collagen,
type I, a2) locus. These findings implicate p300-mediated histone acetylation as a fundamental epigenetic
mechanism in fibrogenesis and place Egr-1 upstream in TGF-b-driven stimulation of p300 gene expression. The
results establish a firm link between fibrosis with aberrant p300 expression and epigenetic activity that, to our
knowledge, is previously unreported. Targeted disruption of p300-mediated histone acetylation might therefore
represent a viable antifibrotic strategy.
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INTRODUCTION
The ubiquitous nuclear phosphoprotein p300 is a component of
the chromatin remodeling and transcriptional complex that
modulates the expression of genes involved in cell cycle regula-
tion, apoptosis, growth, and development (Goodman and Smolik,
2000). The histone acetyltransferase (HAT) domain enables p300
to catalyze histone acetylation and augment activator-dependent
transcription (Kraus and Kadonaga, 1998; Vo and Goodman,
2001). In addition to chromatin histone, p300 can also catalyze
acetylation of early growth response-1 (Egr-1) and other transcrip-
tion factors (Ghosh and Varga, 2007). Although p300 is essential
for normal embryogenesis, altered expression or function is
implicated in the RubinsteinTaybi syndrome, cancer,
neurodegenerative diseases, and other pathologies (Petrij et al.,
1995; Giles et al., 1998; Janknecht, 2002; Iyer et al., 2004;
Roelfsema et al., 2005; Saha and Pahan, 2006). Recent studies
reveal important roles for p300 in the regulation of extracellular
matrix homeostasis, myofibroblast transformation, and
epithelialmesenchymal transition (Ghosh and Varga, 2007;
Kaimori et al., 2010; Yokomizo et al., 2011; Lim et al., 2012).
We have shown previously that the HAT activity of p300
and its interaction with activated Smads are essential for
transforming growth factor-b (TGF-b)-induced profibrotic
signaling (Ghosh et al., 2000, 2001, 2004, 2009). Moreover,
levels of p300 are limiting in normal fibroblasts, and ectopic
expression of p300 markedly enhanced the magnitude of TGF-
b responses, whereas ribozyme-mediated knockdown of
cellular p300 resulted in selective abrogation of the
stimulation of collagen gene expression. Levels of p300
were significantly elevated in explanted systemic sclerosis
(SSc) fibroblasts (Bhattacharyya et al., 2005) and in skin from
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mice with chronic graft-versus-host disease–associated skin
fibrosis, suggesting that p300 might have an important role in
the pathogenesis of SSc.
Surprisingly, the regulation of p300 expression and activity
under physiological and pathological conditions has received
scant attention. The present studies demonstrate that p300
expression was significantly elevated in SSc skin biopsies and
was markedly stimulated by TGF-b in explanted normal
fibroblasts by a Smad-independent pathway. Increased p300
abundance in TGF-b-stimulated fibroblasts, as well as in cells
conditionally overexpressing p300, was associated with p300
accumulation on target gene promoters, histone H4 acetyla-
tion, and elevated Type I collagen transcriptional activity.
These results establish an important mechanistic link between
TGF-b signaling, excessive collagen gene expression, and
fibrosis that is mediated through Egr-1 induction of p300
and histone hyperacetylation at the collagen gene promoter.
Precise delineation of the molecular events underlying fibro-
genesis and the role of p300 in TGF-b-inducible transcrip-
tional responses may accelerate the development of targeted
therapies to control the progression of fibrosis in SSc.
RESULTS
Elevated levels of p300 in SSc
We have previously shown that p300 levels were elevated in
explanted SSc fibroblasts (Bhattacharyya et al., 2005). We
confirmed this finding in additional fibroblasts from patients
with diffuse SSc (Figure 1a). We next evaluated biopsies of
lesional skin from 10 patients with SSc and of dorsal forearms
from five healthy controls by immunohistochemistry. The results
showed markedly increased p300 immunostaining in SSc biop-
sies (Figure 1b and c). In the SSc lesional dermis, p300 was
localized largely to the nucleus in fibroblast-like cells. Staining
with isotype control antibodies indicated the specificity of anti-
p300 antibodies. The intensity of cellular p300 staining in diffuse
cutaneous SSc biopsies showed a modest positive correlation
with the modified Rodnan skin score (slope¼ 0.23, R2¼0.29).
TGF-b stimulates p300 gene expression
In view of the increased expression of p300 in SSc skin
biopsies and its pivotal role in mediating TGF-b-induced
profibrotic responses, we investigated the regulation of p300
expression by TGF-b. The results of semiquantitative PCR,
western blot, and immunofluorescence analyses revealed that
in normal fibroblasts, TGF-b enhanced the levels of p300
(Figure 2a and b). Stimulation could be detected as early as
6 hours, with a maximal 43-fold increase at 48 hours.
Remarkably, in contrast to p300, levels of CBP, a p300
paralog with comparable HAT and coactivator function,
remained unaltered in TGF-b-treated fibroblasts (data not
shown). Northern analysis revealed that stimulation of p300
mRNA expression by TGF-b was concentration dependent,
with a maximal 43-fold increase (Figure 2c).
A series of experiments were performed in neonatal
and adult skin fibroblasts to address the mechanisms under-
lying p300 stimulation. To examine changes in the stability of
p300 mRNA transcripts, fibroblasts were incubated with TGF-
b in the presence or absence of actinomycin D (5mg ml1),
followed by determination of mRNA levels at the indicated
intervals. The results of reverse transcriptase–PCR showed
that p300 mRNA level declined at a comparable rate in the
absence or presence of TGF-b, with an estimated half-life of
6–9 hours (Figure 2d). To evaluate the effect of TGF-b on p300
gene transcription, confluent NIH3T3 fibroblasts were
transiently transfected with p300-luc reporter constructs. After
24 hours of incubation in serum-free media containing TGF-b,
cultures were harvested and luciferase activities were
determined. The results indicated that TGF-b induced a
42-fold stimulation of luciferase activity driven by a
p300 promoter (Figure 2e). Addition of serum strongly stimu-
lated p300 promoter activity in transfected fibroblasts, con-
sistent with previous reports in prostate cancer cells (Yu et al.,
2004). Together, these results indicate that p300 gene
expression is stimulated by TGF-b through transcriptional
stimulation.
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Figure 1. Enhanced expression of p300 in systemic sclerosis (SSc) fibroblasts and skin biopsies. (a) Fibroblasts explanted from a healthy adult control and
patients with diffuse SSc (dSSc) were incubated with transforming growth factor-b (TGF-b) for 24 hours. Whole-cell lysates were analyzed by western blotting
followed by densitometry. The results show relative fold changes normalized with actin. Arrow indicates actin bands. (b, c) Skin biopsies from 10 SSc patients and
five healthy controls were stained with anti-p300 antibodies or isotype control. (b) Representative images of randomly selected microscopic fields (upper panels,
bar¼ 80mm; lower panels, bar¼ 20mm). Arrows indicate immunopositive dermal cells with the nuclear staining. (c) Dot-plot of p300 score in healthy control and
SSc patients. The intensity of p300 staining in each slide was quantified as described in the Materials and Methods.
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Stimulation of p300 is Smad independent
Pretreatment of the cultures with a selective inhibitor of ALK5-
mediated Smad2/3 phosphorylation (SB431542) did not block
the stimulation of p300 induced by TGF-b, whereas it
significantly reduced Smad2 phosphorylation (80% reduction
in lane 6 compared with lane 2; Figure 3a). In sharp contrast,
the extracellular signal–regulated kinase 1/2 (ERK1/2) inhibitor
PD98059 completely prevented the stimulation (Figure 3a).
Consistent with these results, TGF-b stimulated p300 mRNA
levels with a comparable magnitude in Smad3-null and
wild-type mouse embryonic fibroblasts (MEFs; 90±18% in
wild-type MEFs and 86±3% in Smad3 / MEFs, P¼ not
significant, data not shown). Moreover, transient transfection
assays showed that the ERK1/2 inhibitor, but not the ALK5
inhibitor, abrogated the stimulation of p300 promoter activity
(Figure 3b). Identical Smad-independent TGF-b stimulation of
p300 expression was seen in human adult skin fibroblasts
incubated with TGF-b (Figure 3c).
Stimulation of p300 is mediated by Egr-1
We demonstrated previously that expression of Egr-1 was
stimulated by TGF-b in a variety of cell types in a rapid and
transient manner and requiring ERK1/2, but not Smads
(Bhattacharyya et al., 2011). Moreover, Egr-1 was both
necessary and sufficient for TGF-b stimulation of collagen
gene expression. Inspection of the human p300 gene promoter
revealed the presence of multiple conserved Egr-1 recognition
sites (data not shown), suggesting a potential role for Egr-1 in
the regulation of p300. To investigate this possibility directly,
Egr-1 was ectopically expressed in normal fibroblasts with/
without TGF-b. The results from multiple transfection assays
demonstrated that Egr-1 by itself was capable of enhancing
p300 expression, with a magnitude of stimulation comparable
to that induced by TGF-b (Figure 4a). To define the role of
DNA-binding activity of Egr-1 in mediating transactivation, we
used a mutant p300 promoter construct harboring base
changes disrupting all six Egr-1-binding sites (Yu et al.,
2004). Transient transfection of this Egr-1–unresponsive
mutant p300 promoter revealed reduced basal
transcriptional activity and, importantly, complete abrogation
of the TGF-b stimulatory response (Figure 4b). To directly
examine the role of Egr-1 in p300 regulation, we next used
fibroblasts lacking Egr-1. For this purpose, MEFs from Egr-1 /
mice and Egr-1þ /þ wild-type littermates were grown to
confluence in parallel and then incubated with TGF-b.
Western analysis revealed that absence of cellular Egr-1 was
associated with decreased levels of p300 and a substantial loss
of the TGF-b stimulatory response (Figure 4c). The role of
Egr-1 in TGF-b-induced p300 expression was next examined
in vivo. For this purpose, Egr-1 / mice and wild-type
littermates were injected in parallel with TGF-b. Analysis of
mRNA directly isolated from the injected skin revealed that in
the absence of Egr-1, TGF-b failed to induce p300 expression
in vivo (Figure 4d). Consistent results at the level of protein
expression were obtained by immunofluorescence (Figure 4e).
The results from these in vitro and in vivo experiments
collectively establish the indispensible role of Egr-1 in the
regulation of p300 by TGF-b.
TGF-b induces p300-dependent histone H4 hyperacetylation
Maximal stimulation of collagen synthesis by TGF-b depends
on the acetyltransferase activity of p300 (Ghosh et al., 2000).
In light of its importance, we sought to investigate the role of
p300-mediated histone H4 acetylation in fibrotic responses
elicited by TGF-b. Confluent fibroblasts were incubated
with TGF-b for 24 hours, and total cellular histones were
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Figure 2. Transforming growth factor-b (TGF-b) augments the levels of p300. (a–d) Confluent dermal fibroblasts were incubated with TGF-b2 (12.5 ng ml1
unless otherwise indicated). (a) At the end of the experiments, whole-cell lysates and RNA were harvested and examined by western blot or semiquantitative
reverse transcriptase–PCR (RT–PCR). Upper panels, western blot; lower panels, semiquantitative RT–PCR. Representative images. (b) Fibroblasts were stained with
40,6-diamidino-2-phenylindole (DAPI; nuclei: blue) or anti-p300 antibodies (green) and viewed under a fluorescent microscope. Original magnification  400.
Representative images. (c) After 10 hours of incubation, total RNA was isolated and subjected to northern analysis. GAPDH, glyceraldehyde-3-phosphate
dehydrogenase. (d) Fibroblasts were incubated with TGF-b2 for 24 hours. Actinomycin D was added for a further 6 or 24 hours, and mRNA levels were
analyzed by RT–PCR. (e) NIH3T3 fibroblasts were transfected with pGL3-p300-luc, and then incubated in serum-free media with TGF-b2 or in media
with 20% fetal bovine serum (FBS). Whole-cell lysates were assayed for luciferase activities. The results represent the mean±SEM of triplicate determinations.
*Po0.05.
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acid-extracted. Western analysis showed that TGF-b induced a
significant increase in acetylated histone H4, whereas levels of
total histone H4 remained unaltered (Figure 5a). The role of
p300 in TGF-b-induced histone hyperacetylation was further
evaluated by complementary gain-of-function and loss-of-
function experiments. Ad-Tet infection of fibroblasts stably
expressing inducible p300 resulted in markedly increased
accumulation of p300 in these cells, which was associated
with significantly enhanced histone H4 acetylation
(Figure 5b). To further examine the contribution of p300 in
the TGF-b response, endogenous p300 was knocked down in
normal dermal fibroblasts using p300-specific ribozymes. The
results of western analysis demonstrated that although TGF-b
treatment resulted in increased histone H4 acetylation in
control fibroblasts, ribozyme-mediated depletion of cellular
p300 substantially abrogated the response (Figure 5c). The
effects of TGF-b on the recruitment of p300 to the COL1A2
(collagen, type I, a2) promoter, and associated locus-specific
histone acetylation in vivo, were examined next. The results of
chromatin immunoprecipitation (ChIP) assays revealed
markedly elevated p300 accumulation and histone H4 acet-
ylation at the Smad-binding region of COL1A2 promoter in
fibroblasts incubated with TGF-b (Figure 6a).
To directly establish the functional significance of the
acetyltransferase activity of p300 in the fibrotic responses
elicited by TGF-b, we used anacardic acid, a selective
pharmacological inhibitor of HAT activity (Eliseeva et al.,
2007). Confluent cultures were pretreated with anacardic
acid, followed by incubation with TGF-b. Pharmacological
inhibition of HAT activity markedly abrogated the stimulation
of collagen expression induced by TGF-b (Figure 6b). Taken
together, these results indicate that enhanced p300 expression
and HAT activity in TGF-b-stimulated fibroblasts resulted in
increased histone H4 acetylation that was associated with,
and directly responsible for, upregulation of fibrotic gene
expression in these cells.
DISCUSSION
Previous studies have identified an essential role for p300
acetyltransferase and its interaction with Smads in TGF-b-
induced profibrotic responses (Ghosh et al., 2000, 2001,
2004, 2009; Czuwara-Ladykowska et al., 2002). Despite its
critical role in modulating profibrotic responses elicited by
TGF-b and other mediators, the regulation of p300 expression
and activity, as well as the mechanisms underlying their
derangement in fibrotic diseases, have received scant
attention to date.
The present results reveal that levels of p300 are signifi-
cantly elevated in lesional skin biopsies from patients with
SSc. Moreover, the expression of p300 in explanted normal
fibroblasts was markedly upregulated by TGF-b. Stimulation
involved the canonical Smad-independent ERK1/2-mediated
upregulation of the early-immediate transcription factor Egr-1,
which then directly stimulated p300 gene transcription.
Treatment of the fibroblasts with TGF-b also resulted in
enhanced histone H4 hyperacetylation, concomitant with
increased p300 accumulation at the COL1A2 promoter.
Moreover, pharmacological blockade of HAT activity using
anacardic acid abrogated the stimulation of collagen gene
expression elicited by TGF-b. Taken together with the previous
demonstration that augmented p300 expression in fibroblasts
sensitized them to the profibrotic effects of TGF-b, the present
results provide previously unreported insight into the mechan-
ism of fibrosis in SSc and indicate a fundamental role of
acetyltransferase p300-mediated histone modifications in
mediating this process.
Elevated p300 levels were seen in the skin from mice with
bone-marrow transplantation–induced chronic graft-versus-
host disease (Bhattacharyya et al., 2005). Similar
upregulation of p300 was also observed in the skin from
mice with bleomycin-induced scleroderma (M Wu et al.,
unpublished results). The expression of p300 is elevated in
explanted SSc skin fibroblasts (Bhattacharyya et al., 2005).
Other studies linking fibrosis and p300 showed that the
activated SSc fibroblast phenotype was attributed to ligand-
independent constitutive association of p300 with Smad2/3
and consequent transcriptional activation of target genes (Ihn
et al., 2006). The mechanisms accounting for the increased
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Figure 3. p300 stimulation by transforming growth factor-b (TGF-b) is
mediated by extracellular signal–regulated kinase 1/2 (ERK1/2). (a) Confluent
fibroblasts were preincubated with SB431542 (left panel) or PD98059 (right
panel) followed by TGF-b2 (12.5 ng ml 1) for 24 hours. Whole-cell lysates
were examined by immunoblot analysis. (b) NIH3T3 fibroblasts transfected
with p300-luc were preincubated with SB431542 or PD98059, followed by
TGF-b for 24 hours. Whole-cell lysates were assayed for their luciferase
activities. Open bars indicate untreated fibroblasts and closed bars indicate
TGF-b-treated fibroblasts. The results normalized with protein concentration
represent mean±SD of triplicate determinations. *Po0.05. (c) Confluent
normal adult dermal fibroblasts were preincubated with SB431542 or U0126
followed by TGF-b2 for 24 hours. The real-time quantitative PCR results,
normalized with glyceraldehyde-3-phosphate dehydrogenase (GAPDH),
represent the mean±SD of triplicate determinations from the representative
experiment. *Po0.05.
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accumulation of p300 in the lesional SSc skin, and its
persistence in explanted SSc fibroblasts, remain unknown. It
is noteworthy that elevated p300 expression has been reported
in fibrotic kidneys from patients with glomerulonephritis
(Kassimatis et al., 2006), as well as in a mouse model of
lung fibrosis (Liu et al., 2004). The levels of p300 are elevated
in various tumors (Li et al., 2011a, b). Moreover, the relative
tissue expression of p300 in these cancers correlates with
tumor aggressiveness and survival, suggesting a potential role
for p300 as a biomarker of disease severity. Importantly,
selective inhibition of p300 acetyltransferase activity with a
small molecule blocked profibrotic TGF-b responses in normal
fibroblasts in the present studies and was shown to reduce the
invasiveness of prostate cancer cells displaying elevated p300
(Santer et al., 2011). Taken together, these observations
suggest that p300 has a fundamental role in progression of
fibrosis and cancer, and therefore determining its levels may
serve as disease biomarkers in these conditions.
As TGF-b can stimulate collagen gene expression by both
canonical and Smad-independent signaling pathways (Ghosh,
2002; Varga, 2002), we investigated the role of the TGF-b
receptor kinase and activation of downstream Smads in p300
regulation. Surprisingly, we found that an ERK1/2 kinase
inhibitor, but not an ALK5 inhibitor, blocked the stimulation
of p300 by TGF-b. The early-immediate transcription factor
Egr-1 has an indispensible role in fibrogenesis, and its
expression is constitutively elevated in SSc biopsies
(Bhattacharyya et al., 2011). Egr-1 has been implicated in
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transfected with Egr-1 or empty vector and harvested following 24 hours of incubation with TGF-b. Whole-cell lysates were subjected to western blotting.
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wild-type littermates were incubated with TGF-b (12.5 ng ml1) for 2–24 hours. Whole-cell lysates were examined by western analysis. Arrow indicates actin
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the regulation of p300 expression in prostate cancer cells (Yu
et al., 2004). In these cells, incubation with serum triggered a
potent upregulation of p300. We have shown previously that
in normal skin fibroblasts, Egr-1 was rapidly and transiently
induced by TGF-b by a Smad-independent pathway (Chen
et al., 2006; Bhattacharyya et al., 2011). Egr-1 stimulated
collagen transcription by binding to collagen promoter (Chen
et al., 2006). Here we found that Egr-1 directly augmented
p300 gene expression and further enhanced the TGF-b-
induced stimulation. In contrast, TGF-b failed to stimulate
p300 transcription from a promoter with disrupted Egr-1-
binding sites. On the basis of these findings, we propose a
complex signaling relay network. As levels of Egr-1, p300, and
collagen are all significantly elevated in lesional SSc tissues,
the fibrogenic TGF-b-Egr-1-p300-HAT activity and
chromatin remodeling-target gene transcription relay
pathway is likely to contribute to the progression of fibrosis
in a concerted way (Figure 6c).
Taken together, these results demonstrate that p300, a
ubiquitous transcriptional coactivator and epigenetic regulator
that is required for optimal Smad-dependent profibrotic
responses, is itself a target of TGF-b signaling. Lesional tissue
levels of p300 are significantly elevated in mouse models of
scleroderma and pulmonary fibrosis, as well as in SSc skin
biopsies and in explanted SSc skin fibroblasts. Induction of
p300 by TGF-b is dependent on Egr-1, which directly binds to
regulatory DNA elements in the p300 gene and stimulates its
transcription. Augmented abundance of cellular p300 is
associated with enhanced intensity of profibrotic TGF-b
signaling due to increased histone H4 hyperacetylation and
Smad-dependent transcription. Because the cellular availabil-
ity of p300 governs the intensity of TGF-b responses, Egr-1-
mediated upregulation of p300 expression and epigenetic
activity is expected to augment the stimulation of collagen
and other fibrotic genes and thus has a vital role in the
pathogenesis of fibrosis. Small molecules are available to
selectively disrupt the histone acetyltransferase activity of
p300. Inducing competition for limiting amounts of cellular
p300 using agents that activate the AMP kinase pathways,
cyclic AMP, or peroxisome proliferator–activated receptor-g
might represent alternate ‘‘drug repurposing’’ approaches for
repressing p300 function. Therefore, blocking the stimulation
of p300 expression or activity might represent innovative
therapeutic strategies to control TGF-b-mediated fibrogenesis.
MATERIALS AND METHODS
Human subjects
Skin biopsies were obtained from the dorsal forearm of five healthy
adults and from the lesional skin of 10 SSc patients (see clinical
characteristics in Supplementary Table S1 online). Fibroblasts were
explanted from biopsies of lesional skin from patients with diffuse SSc
and a healthy adult and studied at early passage. All skin biopsies
were performed with written informed consent and in compliance
with the Institutional (Boston University and Northwestern University)
Review Board for Human Studies, in adherence to the Declaration of
Helsinki Principles.
Cell cultures
Primary cultures of dermal fibroblasts were established by explanta-
tion from neonatal foreskin or adult skin (Chen et al., 1999). MEFs
explanted from Smad3 / or wild-type embryos were maintained in
DMEM. Culture and infection of Rat-12 cells harboring Tet-inducible
p300 were described previously (Baluchamy et al., 2003). At
confluence, cultures were incubated with indicated concentrations
of TGF-b2 (Genzyme, Framingham, MA), the ALK5 inhibitor
SB431542 (Glaxo SmithKline, King of Prussia, PA), the ERK1/2
kinase inhibitor PD98059 or U0126 (Sigma, St Louis, MO), or
actinomycin D (Cell Signaling, Beverly, MA). To reach maximum
induction of fibrotic responses, 12.5 ng ml 1 TGF-b was used in
selected experiments. The HAT inhibitor anacardic acid (EMD
Millipore, Billerica, MA) was added to the cultures 60 minutes
before TGF-b.
Plasmids, transient transfection, and reporter assays
The pGL3 p300-luc, pGL3 p300-luc-abcdef, PCB-pCMV-Egr-1, and
p300-specific ribozyme constructs were from Dr Adamson (Yu et al.,
2004). Confluent foreskin fibroblasts were transiently cotransfected
with reporter and expression vectors or empty vectors using Superfect
reagent (Qiagen, Valencia, CA) and incubated with TGF-b2
(12.5 ng ml 1) for up to 48 hours. Transfection with pRLTK-luc was
used as an internal control.
Histone extraction and ChIP assays
Confluent cultures of fibroblasts were incubated with TGF-b (12.5 ng /
ml 1). After 24 hours, cultures were harvested and histones were
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Figure 5. Transforming growth factor-b (TGF-b) induces p300-mediated
histone H4 hyperacetylation. (a) Fibroblasts were incubated with TGF-b2
(12.5 ng ml1) for 24 hours. Total histones were extracted and analyzed by
western blotting followed by densitometry. (a, lower panel) Quantitation.
The results show levels of AcH4 histone normalized to total H4 histone
(mean±SD) from three independent experiments (a, lower panel). *Po0.05.
(b) Rat-12 fibroblasts stably expressing conditional p300 were infected with
Ad-b-gal or Ad-Tet to induce p300 expression, and whole-cell lysates were
examined by western analysis. Arrow indicates actin bands. (c) Foreskin
fibroblasts transfected with p300-specific ribozyme or inactive ribozyme were
incubated with TGF-b2 (12.5ng ml 1) for 48 hours. Whole-cell lysates were
analyzed by western blot.
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extracted as described (Ghosh et al., 2007). ChIP assays were
performed using the EZ magna ChIP Assay Kit (Upstate/Millipore,
Billerica, MA) as described previously (Ghosh et al., 2009). PCR
amplification of the captured DNA sequences was performed using
primers complementary to COL1A2 sequences flanking the Smad-
binding element.
Western analysis
After incubation with TGF-b for indicated periods, adult human
dermal fibroblasts, foreskin fibroblasts, or rat fibroblasts were har-
vested and whole-cell lysates were prepared using M-PER lysis buffer
(Pierce, Rockford, IL). Equal aliquots of total proteins or acid-extracted
histones were electrophoresed on 4–20% Tris-Glycine gradient gels
(Bio-Rad, Hercules, CA), followed by immunoblot analysis using
primary antibodies against phospho-ERK1 (Cell Signaling), p300 and
actin (Santa Cruz Biotech, Santa Cruz, CA), and total histone H4 or
acetylated histone H4 (Ac-H4;Upstate/Millipore). Blots were washed
with Tris-buffered saline and Tween-20 buffer, followed by incuba-
tion with appropriate horseradish peroxidase–conjugated secondary
antibodies, and antigen–antibody complexes were visualized
by chemiluminescence (ECL Reagent, Amersham BioSciences,
Piscataway, NJ). To quantify the bands obtained from western blot,
developed films were scanned in grayscale and analyzed by ImageJ
software (http://rsb.info.nih.gov/ij/).
Immunohistochemistry and immunofluorescence
Sections of human skin biopsies were deparaffinized, rehydrated, and
blocked for 30 minutes with 3% BSA in Tris-buffered saline (pH 7.4),
and then incubated overnight with anti-p300 antibody (Santa Cruz).
Slides were then incubated for 30 minutes with a biotinylated donkey
anti-rabbit secondary antibody followed by streptavidin-linked alka-
line phosphatase (Jackson Immuno Research, West Grove, PA), or
with alkaline phosphatase–conjugated anti-mouse/anti-rabbit anti-
body (DakoCytomation, Carpinteria, CA) for 30 minutes and detected
with Fast Red (DakoCytomation).
Quantification was performed by two independent observers, and
the intensity of staining was recorded for at least 200 individual
fibroblasts using a scale of 0–3 (0¼ no visible staining, 1¼ faint
staining observable, 2¼moderate staining, and 3¼ strong staining).
The average intensity of fibroblast staining was calculated on the basis
of images obtained from random fields throughout the dermis of the
whole tissue section.
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Figure 6. Transforming growth factor-b (TGF-b) induces p300 recruitment and histone acetyltransferase (HAT)-dependent fibrotic responses. (a) Fibroblasts were
incubated with TGF-b2 (12.5ng ml 1) for 60 minutes, and whole-cell lysates were subjected to chromatin immunoprecipitation (ChIP) assays using antibodies to
p300 or acetylated histone H4. Immunoprecipitated chromatins were reverse crosslinked and purified DNA was subjected to PCR (left panels) and real-time
quantitative PCR (right panels) using primers to amplify Smad-binding region of Col1A2 (collagen, type I, a2) promoter. The results represent the mean±SD of
triplicate determinations. *Po0.05. (b) Adult skin fibroblasts were pretreated with anacardic acid (ANA), followed by incubation with TGF-b for 24 hours. Results
of real-time quantitative PCR shown as mean±SEM. *Po0.05. (c) Illustration of the TGF-b-Egr-1-p300-chromatin remodeling-fibrotic response relay system.
In mesenchymal cells, TGF-b stimulates Egr-1 expression, which activates transcription of both COL1A2 and p300. In turn, p300 causes COL1A2 promoter
chromatin histone acetylation, facilitating transcriptional activation by Smad2/3. Elevated levels of p300 enhance Smad2/3-dependent transcriptional activity.
EBS, Egr-binding site; Egr-1, early growth response gene-1; SBE, Smad-binding element.
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To examine the role of Egr-1 in the regulation of p300 expression
in vivo, 6- to 8-week-old Egr-1 knockout mice in the C57BL/6
background (Wu et al., 2009) and wild-type littermates were used
under protocols that were institutionally approved by the Northwestern
University Animal Care and Use Committee. Mice were injected with
TGF-b (250 ng) or phosphate-buffered saline. After 48hours, mice were
killed, 4mm-thick sections from dorsal skin were deparaffinized,
rehydrated, and immersed in Tris-buffered saline and Tween-20
buffer, and treated with target retrieval solution (DAKO, Carpinteria,
CA). Sections were incubated with anti-p300 antibody (Santa Cruz), and
bound antibodies were detected using an Alexa488-conjugated donkey
anti-rabbit antibody (Invitrogen, Grand Island, NY). Rabbit control IgG
was used as negative control. Sections were counterstained with 40,6-
diamidino-2-phenylindole for nuclei. After washing, slides were
examined under a Zeiss UV Meta 510 confocal microscope (Carl
Zeiss, Jena, Germany).
Northern analysis, reverse transcriptase–PCR, and real-time
quantitative PCR
Total RNA was isolated from confluent fibroblasts using a TRIZOL
reagent (Life Technologies, Grand Island, NY) and examined by
northern analysis or reverse transcriptase–PCR (Bhattacharyya et al.,
2005). Reverse transcription was performed using SuperScript First-
strand synthesis system (Invitrogen) according to the manufacturer’s
protocol. Primers (Sigma Genosys, Woodlands, TX) for PCR were
as follows: p300, sense 50-CTTTACCGTCAGGATCCAG-30, antisense
50-AGTATTTGTATACCCGT ATG-30; and actin, sense 50-ATCT
GGCACCACACCTTCTACAATGAG CTGCG-30, antisense 50- CGTCA
TACTCCTGCTTGTGATCCACATCTGC-30. For real-time qPCR,
reactions were performed on an ABI-Prism 7300 sequence
detection PCR machine (Applied Biosystems, Foster City, CA)
according to the manufacturer’s protocol. The primer sequences are
available upon request. Relative mRNA expression levels were
normalized with glyceraldehyde-3-phosphate dehydrogenase mRNA
levels and determined by calculating DDCt.
Statistical analysis
The data are presented as mean±SD or mean±SEM. Statistical
differences between the experimental and control groups were
determined by analysis of variance. Values of Po0.05 by Student’s
t-test were considered significant.
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